 A kidney disease treatment from Vera lagged rivals from Chinook and Otsuka, analysts said Wednesday as the biotech stock plummeted. The post Why Vera Stock Crashed 60 On Its Positive Kidney Drug Update And Chinook Popped appeared first on Investors Business Daily. 